IN2013MU02045A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02045A
IN2013MU02045A IN2045MU2013A IN2013MU02045A IN 2013MU02045 A IN2013MU02045 A IN 2013MU02045A IN 2045MU2013 A IN2045MU2013 A IN 2045MU2013A IN 2013MU02045 A IN2013MU02045 A IN 2013MU02045A
Authority
IN
India
Prior art keywords
mscs
relates
treating
type
diabetes
Prior art date
Application number
Other languages
English (en)
Inventor
Satish Mahadeorao Totey
Lyle Carl Fonseca
Manoj Kumar C Reddy
Shashank Gowda
Aarya HARI
Basavaraj Chougule
Minita Sodhi
Sneha Deepak Laghate
Nicole Rachel Koshy
Original Assignee
Kasiak Res Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kasiak Res Pvt Ltd filed Critical Kasiak Res Pvt Ltd
Priority to PCT/IN2013/000582 priority Critical patent/WO2014203267A2/en
Priority to IN2045MU2013 priority patent/IN2013MU02045A/en
Publication of IN2013MU02045A publication Critical patent/IN2013MU02045A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN2045MU2013 2013-06-17 2013-09-26 IN2013MU02045A (enExample)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IN2013/000582 WO2014203267A2 (en) 2013-06-17 2013-09-26 Method for isolation, purification and industrial scale expansion of human adipose tissue derived mesenchymal stem cells
IN2045MU2013 IN2013MU02045A (enExample) 2013-06-17 2013-09-26

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2045MU2013 IN2013MU02045A (enExample) 2013-06-17 2013-09-26

Publications (1)

Publication Number Publication Date
IN2013MU02045A true IN2013MU02045A (enExample) 2015-06-05

Family

ID=52105422

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2045MU2013 IN2013MU02045A (enExample) 2013-06-17 2013-09-26

Country Status (2)

Country Link
IN (1) IN2013MU02045A (enExample)
WO (1) WO2014203267A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR20150100378A (el) * 2015-08-25 2017-04-10 Βαλερι-Σεσιλ-Αννα Παντελη Αγγελου Μεθοδος απομονωσης μεσεγχυματικων βλαστικων κυτταρων εκ λιπωδους ιστου
WO2017038784A1 (ja) 2015-08-28 2017-03-09 ロート製薬株式会社 Ｒｏｒ１陽性の間葉系幹細胞及びその調製方法、ｒｏｒ１陽性の間葉系幹細胞を含む医薬組成物及びその調製方法、並びにｒｏｒ１陽性の間葉系幹細胞を用いる疾患の予防又は治療方法
AU2016342387B2 (en) * 2015-10-23 2021-12-09 Rigshospitalet Stem cell therapy based on adipose-derived stem cells
CA3043594C (en) * 2016-11-11 2025-10-07 Longeveron Llc Methods of using human mesenchymal stem cells to effect cellular and humoral immunity
CN110139657A (zh) * 2017-02-15 2019-08-16 日本乐敦制药株式会社 肺纤维化治疗剂、ptprr表达促进剂及肺纤维化治疗用试剂盒
JPWO2018164228A1 (ja) * 2017-03-08 2020-01-09 ロート製薬株式会社 Ｒｏｒ１陽性の間葉系幹細胞を含有する、線維症を伴う疾患の予防又は処置のための医薬組成物、及びその調製方法、並びにｒｏｒ１陽性の間葉系幹細胞を用いる線維症を伴う疾患の予防又は処置方法
WO2019175773A1 (en) 2018-03-12 2019-09-19 Universidade Do Porto Compositions for use in the treatment of musculoskeletal conditions and methods for producing the same leveraging the synergistic activity of two different types of mesenchymal stromal/stem cells
WO2020165404A1 (en) 2019-02-15 2020-08-20 Rigshospitalet Stem cell therapy for lacrimal gland dysfunction
EP3923959A1 (en) 2019-02-15 2021-12-22 Rigshospitalet Stem cell therapy for patients with salivary gland dysfunction
CN111514164A (zh) * 2020-04-30 2020-08-11 深圳市合一康生物科技股份有限公司 一种用于肺病治疗的脂肪间充质干细胞及其制备方法
EP3909593A1 (en) 2020-05-15 2021-11-17 Rigshospitalet Stem cells for treating skin lesions
WO2022115696A2 (en) * 2020-11-30 2022-06-02 Chan Zuckerberg Biohub, Inc. Reconstitution of a split-halotag via orthogonal tag-binding domains
CN112646030B (zh) * 2021-01-11 2021-11-30 内蒙古创润生物科技有限公司 一种包含间充质干细胞外泌体的药物组合物在治疗疾病中的应用
HU231475B1 (hu) * 2021-04-01 2024-02-28 Cellfactory Korlátolt Felelősségű Társaság Eljárás osteoartritisben szenvedő egyed kezelésére szolgáló készítmény előállítására
US20240425815A1 (en) * 2021-09-23 2024-12-26 Aarhus Universitet Ready-to-use stem cell therapeutic

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2687446A1 (en) * 2006-05-17 2007-11-29 Cognate Therapeutics, Inc. Isolation and purification of hematopoietic stem cells from post-liposuction lipoaspirates
WO2011043147A1 (ja) * 2009-10-06 2011-04-14 国立大学法人名古屋大学 脂肪組織由来間葉系幹細胞を含有する、勃起不全又は尿意障害用の細胞製剤
ES2897598T3 (es) * 2009-11-27 2022-03-01 Stempeutics Res Pvt Ltd Métodos de preparación de células madre mesenquimales, composiciones y kit de las mismas
EP2333047A1 (en) * 2009-12-09 2011-06-15 Fresenius Medical Care Deutschland GmbH Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease
US8962331B2 (en) * 2010-02-01 2015-02-24 The Board Of Trustees Of The Leland Stanford Junior University Method of making induced pluripotent stem cell from adipose stem cells using minicircle DNA vectors
EP2776578A1 (en) * 2011-11-09 2014-09-17 Allocure, Inc. Assay for the prediction of therapeutic effectiveness or potency of mesenchymal stem cells, and methods of using same

Also Published As

Publication number Publication date
WO2014203267A3 (en) 2015-03-26
WO2014203267A2 (en) 2014-12-24

Similar Documents

Publication Publication Date Title
IN2013MU02045A (enExample)
IN2013MU02046A (enExample)
BR112018004377A2 (pt) cepas de levedura para a expressão e secreção de proteínas heterólogas em temperaturas elevadas
ECSP17039547A (es) Nuevas normalizaciones y dispositivos médicos para la preparación de plasma rico en plaquetas (prp) o concentrado de médula ósea (bmc) solos o combinados con ácido hialurónico
MX2019012223A (es) Anticuerpos anti-cd137 y metodos de uso de los mismos.
MY176332A (en) Multispecific antibody constructs
MX2018002315A (es) Anticuerpos anti muerte programada 1 (pd 1) y metodos de uso de los mismos.
IN2015KN00262A (enExample)
MY186892A (en) Utilizing a multiphase reactor for the conversion of biomass to produce substituted furans
MX2015015188A (es) Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab.
MX2015015312A (es) Proceso para la sintesis de 5-hidroximetilfurfural a partir de sacaridos.
PH12016501777A1 (en) Novel lactobacillus paracasei strain
UA109575C2 (uk) Спосіб термічної стерилізації медичного контейнера
MY189932A (en) Recombinant microorganism for improved production of alanine
EA201691754A1 (ru) Рекомбинантный микроорганизм, экспрессирующий аналог авермектина, и его применение
MY174468A (en) Bio-based arcylic acid and its derivatives
MX2016000480A (es) Composiciones farmaceuticas de pancreatina de alta potencia.
CO6430457A2 (es) Proceso para la preparación de amidas del ácido pirazol carboxilico
MX2015010694A (es) Peptidos funcionales para trastornos de obesidad.
PH12013501951A1 (en) Agent for improving or maintaining qol
IN2013MU02047A (enExample)
WO2015057836A3 (en) Bone anabolic parathyroid hormone and parathyroid hormone related-protein analogs
IN2014DN08178A (enExample)
MY186559A (en) O-acetylhomoserine sulfhydrylase variant and method for producing l-methionine using same
MY174840A (en) Microorganism producing o-acetyl-homoserine, and method for producing o-acetyl-homoserine by using same